Neville Rodie & Shaw’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $11.3M | Sell |
87,699
-125
| -0.1% | -$14.6K | 0.73% | 34 |
|
|
2026
Q1 | $10.6M | Hold |
87,824
| – | – | 0.77% | 35 |
|
|
2025
Q4 | $9.24M | Sell |
87,824
-35,140
| -29% | -$3.3M | 0.65% | 37 |
|
|
2025
Q3 | $10.3M | Sell |
122,964
-19,600
| -14% | -$1.61M | 0.75% | 37 |
|
|
2025
Q2 | $11.3M | Sell |
142,564
-24,627
| -15% | -$1.96M | 0.84% | 33 |
|
|
2025
Q1 | $15M | Sell |
167,191
-10,174
| -6% | -$950K | 1.18% | 25 |
|
|
2024
Q4 | $17.6M | Buy |
177,365
+1,382
| +0.8% | +$142K | 1.29% | 21 |
|
|
2024
Q3 | $20M | Sell |
175,983
-7,060
| -4% | -$839K | 1.47% | 19 |
|
|
2024
Q2 | $22.7M | Sell |
183,043
-1,725
| -0.9% | -$222K | 1.72% | 17 |
|
|
2024
Q1 | $24.4M | Sell |
184,768
-845
| -0.5% | -$104K | 1.86% | 14 |
|
|
2023
Q4 | $20.2M | Sell |
185,613
-2,355
| -1% | -$244K | 1.65% | 16 |
|
|
2023
Q3 | $19.4M | Sell |
187,968
-380
| -0.2% | -$41K | 1.73% | 16 |
|
|
2023
Q2 | $21.7M | Sell |
188,348
-4,611
| -2% | -$524K | 1.87% | 13 |
|
|
2023
Q1 | $20.5M | Sell |
192,959
-600
| -0.3% | -$64.8K | 1.86% | 11 |
|
|
2022
Q4 | $21.5M | Buy |
193,559
+3,300
| +2% | +$337K | 2.02% | 10 |
|
|
2022
Q3 | $16.4M | Sell |
190,259
-3,964
| -2% | -$354K | 1.61% | 17 |
|
|
2022
Q2 | $17.7M | Sell |
194,223
-5,631
| -3% | -$499K | 1.59% | 16 |
|
|
2022
Q1 | $16.7M | Sell |
199,854
-1,590
| -0.8% | -$125K | 1.24% | 27 |
|
|
2021
Q4 | $15.4M | Sell |
201,444
-1,195
| -0.6% | -$95.2K | 1.09% | 31 |
|
|
2021
Q3 | $15.2M | Sell |
202,639
-26,440
| -12% | -$2.01M | 1.18% | 28 |
|
|
2021
Q2 | $17.8M | Sell |
229,079
-22,744
| -9% | -$1.69M | 1.37% | 22 |
|
|
2021
Q1 | $18.5M | Sell |
251,823
-2,473
| -1% | -$182K | 1.53% | 19 |
|
|
2020
Q4 | $19.8M | Sell |
254,296
-11,178
| -4% | -$855K | 1.72% | 15 |
|
|
2020
Q3 | $21M | Sell |
265,474
-1,495
| -0.6% | -$117K | 1.98% | 11 |
|
|
2020
Q2 | $19.7M | Sell |
266,969
-681
| -0.3% | -$51.3K | 2.03% | 11 |
|
|
2020
Q1 | $19.6M | Sell |
267,650
-289
| -0.1% | -$22.7K | 2.39% | 9 |
|
|
2019
Q4 | $23.3M | Sell |
267,939
-1,169
| -0.4% | -$96K | 2.28% | 8 |
|
|
2019
Q3 | $21.6M | Sell |
269,108
-5,790
| -2% | -$464K | 2.29% | 7 |
|
|
2019
Q2 | $22M | Sell |
274,898
-4,813
| -2% | -$369K | 2.33% | 7 |
|
|
2019
Q1 | $22.2M | Sell |
279,711
-4,973
| -2% | -$372K | 2.35% | 7 |
|
|
2018
Q4 | $20.8M | Sell |
284,684
-3,390
| -1% | -$239K | 2.52% | 5 |
|
|
2018
Q3 | $19.5M | Sell |
288,074
-4,832
| -2% | -$308K | 1.93% | 9 |
|
|
2018
Q2 | $17M | Buy |
292,906
+1,382
| +0.5% | +$78K | 1.79% | 10 |
|
|
2018
Q1 | $15.2M | Sell |
291,524
-3,565
| -1% | -$193K | 1.67% | 12 |
|
|
2017
Q4 | $15.8M | Sell |
295,089
-5,606
| -2% | -$311K | 1.67% | 10 |
|
|
2017
Q3 | $18.4M | Sell |
300,695
-8,182
| -3% | -$496K | 2.05% | 5 |
|
|
2017
Q2 | $18.9M | Sell |
308,877
-1,991
| -0.6% | -$121K | 2.16% | 5 |
|
|
2017
Q1 | $18.8M | Sell |
310,868
-7,281
| -2% | -$442K | 2.16% | 4 |
|
|
2016
Q4 | $17.9M | Sell |
318,149
-594
| -0.2% | -$34.8K | 2.11% | 5 |
|
|
2016
Q3 | $19M | Sell |
318,743
-1,546
| -0.5% | -$90.4K | 2.23% | 5 |
|
|
2016
Q2 | $17.6M | Sell |
320,289
-4,956
| -2% | -$264K | 2.11% | 5 |
|
|
2016
Q1 | $16.4M | Sell |
325,245
-2,908
| -0.9% | -$142K | 2% | 6 |
|
|
2015
Q4 | $16.5M | Sell |
328,153
-576
| -0.2% | -$29K | 1.99% | 7 |
|
|
2015
Q3 | $15.5M | Sell |
328,729
-6,913
| -2% | -$367K | 1.9% | 7 |
|
|
2015
Q2 | $18.2M | Sell |
335,642
-16,795
| -5% | -$942K | 2% | 5 |
|
|
2015
Q1 | $19.3M | Sell |
352,437
-222
| -0.1% | -$12.6K | 2.01% | 5 |
|
|
2014
Q4 | $19.1M | Sell |
352,659
-2,261
| -0.6% | -$126K | 1.93% | 6 |
|
|
2014
Q3 | $20.1M | Buy |
354,920
+12,768
| +4% | +$717K | 1.98% | 5 |
|
|
2014
Q2 | $18.9M | Sell |
342,152
-218
| -0.1% | -$11.9K | 1.9% | 6 |
|
|
2014
Q1 | $18.5M | Sell |
342,370
-10,634
| -3% | -$551K | 2.01% | 7 |
|
|
2013
Q4 | $16.9M | Sell |
353,004
-652
| -0.2% | -$29.8K | 1.82% | 10 |
|
|
2013
Q3 | $16.1M | Sell |
353,656
-5,034
| -1% | -$230K | 1.87% | 8 |
|
|
2013
Q2 | $15.9M | Buy |
+358,690
| New | +$16M | 1.92% | 9 |
|
Other funds holding MRK
ATO
Neville Rodie & Shaw's MRK Position: Q2 2026 in Review
Neville Rodie & Shaw reduced its Merck (MRK) stake by 0.14% in Q2 2026, selling an estimated $14.6K and leaving 87,699 shares worth $11.3M. The position accounts for 0.73% of the portfolio, ranked #34.
Neville Rodie & Shaw first reported a position in MRK in Q2 2013 and has held it in 53 quarters since. The position peaked at $24.4M in Q1 2024. 1,533 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- Neville Rodie & Shaw held 87,699 shares of Merck worth $11.3M as of Q2 2026.
- Neville Rodie & Shaw sold 125 Merck shares in Q2 2026, an estimated $14.6K.
- Merck made up 0.73% of Neville Rodie & Shaw's portfolio in Q2 2026, its #34 holding.
- Neville Rodie & Shaw first reported a position in Merck in Q2 2013 and has held it in 53 quarters since.
- Neville Rodie & Shaw's Merck position peaked at $24.4M in Q1 2024.
- 1,533 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on Neville Rodie & Shaw's 13F filing for Q2 2026, filed 6 Jul 2026.